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Background
Guanylyl cyclase C (GC-C) is a receptor expressed in
intestinal epithelial cells and activation of GCC by its
ligands elevates intracellular cGMP which results in an
inhibition of cell proliferation [1]. Multiple regulatory
mechanisms operate in GC-C to modulate its activity, and
include ligand binding to the extracellular domain, ATP
binding to the kinase homology domain and additional
structural features that link the kinase homology domain
to the C-terminal guanylyl cyclase domain [2]. The persis-
tent expression of GC-C in colorectal carcinomas and
occult metastases makes it a marker for malignancy.
Results
We have investigated cross-talk of GC-C with additional
signalling pathways in the intestinal cell in order to inves-
tigate its role in cell proliferation. Activation of c-src in
human colonic cells results in down-regulation of cGMP
production by GC-C, and through mutational analysis
and invitro and in vivo assays, we show that GC-C is a
substrate for phosphorylation by c-src. This phosphoryla-
tion now results in a reduction in guanylyl cyclase activ-
ity. Phosphorylation of GC-C by c-src allows the docking
of the c-src SH2 domain to phosphorylated GC-C, which
can now result in further activation of c-src. This feed
forward mechanism of activation of c-src, induced by
novel cross-talk between a receptor guanylyl cyclase and
a tyrosine kinase, may have important implications in
colonic tumour progression [3]. To identify other down-
stream effects of cGMP, we have performed microarray
analysis on T84 colon carcinoma cells treated with the
heat-stable enterotoxin. One of the genes significantly
up-regulated, both at the levels of transcript and protein,
was the cell-cycle inhibitor, p21. Treatment of T84 cells
with the stable toxin peptide allowed cells to enter a
cGMP-dependent senescence programme. The cells
show all the hallmarks of senescent cells, including flat-
tened cell morphology, positive staining for SA-ß Gal
and formation of senescence-associated heterochromatic
foci. Activation of senescence and loss of tumorigenicity
in these cells is crucially dependent on the up-regulation
of p21 and therefore can contribute to ST induced-
cytostasis.
Conclusion
These observations may provide an explanation for the
reduced incidence of colon-carcinoma seen in countries
where the incidence of ST-mediated diarrhoea is higher.
Moreover, our results also highlight the fact that the pro-
duction of cGMP in intestinal epithelial cells is exquisitely
regulated, and cGMP, in turn may regulate a number of
pathways with diverse physiological effects.
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